Sourcing High-Purity Osimertinib Intermediates for Oncology R&D
The development of targeted cancer therapies has revolutionized oncology treatment. A key component in this advancement is the availability of high-quality pharmaceutical intermediates, which serve as the foundational building blocks for complex Active Pharmaceutical Ingredients (APIs). Among these crucial compounds is N-(4-fluoro-2-methoxy-5-nitrophenyl)-4-(1-methylindol-3-yl)pyrimidin-2-amine, identified by CAS number 1421372-94-2.
This specific intermediate is critically important for the synthesis of Osimertinib, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI). Osimertinib is specifically designed to target EGFR mutations, including the T790M resistance mutation, which are prevalent in non-small cell lung cancer (NSCLC). For R&D scientists and procurement managers in the pharmaceutical industry, securing a reliable supply of high-purity N-(4-fluoro-2-methoxy-5-nitrophenyl)-4-(1-methylindol-3-yl)pyrimidin-2-amine is paramount to the success of their drug development programs.
As a leading manufacturer and supplier of fine chemicals and pharmaceutical intermediates in China, we understand the stringent requirements for these materials. Our commitment to quality ensures that each batch of N-(4-fluoro-2-methoxy-5-nitrophenyl)-4-(1-methylindol-3-yl)pyrimidin-2-amine meets exacting purity standards, typically exceeding 98% or 99%. This high purity is essential to avoid unwanted side reactions, ensure the efficacy of the final API, and meet regulatory demands. We offer competitive pricing for this vital intermediate, making it accessible for both small-scale research and larger-scale manufacturing needs.
The synthesis of N-(4-fluoro-2-methoxy-5-nitrophenyl)-4-(1-methylindol-3-yl)pyrimidin-2-amine itself involves complex chemical processes. Manufacturers typically employ multi-step synthesis routes, starting from readily available precursors. For example, a common synthetic pathway involves the reaction of 3-(2-chloropyrimidin-4-yl)-1-methylindole with 4-fluoro-2-methoxy-5-nitroaniline in the presence of an acid catalyst. The careful control of reaction conditions, purification techniques, and analytical testing are vital to achieve the desired product specifications. We continuously optimize our production processes to ensure consistent quality and efficient supply.
For companies looking to buy N-(4-fluoro-2-methoxy-5-nitrophenyl)-4-(1-methylindol-3-yl)pyrimidin-2-amine, partnering with a reputable manufacturer is crucial. We pride ourselves on our robust supply chain management, timely delivery, and responsive customer service. Our team is dedicated to supporting your research and development efforts, whether you need samples for initial screening or bulk quantities for preclinical and clinical trials. We encourage you to request a quote for CAS 1421372-94-2 to explore how our high-quality intermediate can benefit your projects and contribute to advancements in cancer treatment.
Perspectives & Insights
Nano Explorer 01
“A key component in this advancement is the availability of high-quality pharmaceutical intermediates, which serve as the foundational building blocks for complex Active Pharmaceutical Ingredients (APIs).”
Data Catalyst One
“Among these crucial compounds is N-(4-fluoro-2-methoxy-5-nitrophenyl)-4-(1-methylindol-3-yl)pyrimidin-2-amine, identified by CAS number 1421372-94-2.”
Chem Thinker Labs
“This specific intermediate is critically important for the synthesis of Osimertinib, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI).”